In LN- patients, RB1 and AKT3 seemed to have a protective effect on patients' cancer-specific survival (p = 0.03 and p = 0.01, respectively) as their higher expression levels were associated with longer survival (in univariate analysis) as shown in Figures 6(a) and 6(b). This evidence concerns the gene AKT3 and cancer.